By Will Feuer

Intuitive Surgical Inc. said the U.S. Food and Drug Administration has cleared its da Vinci SP surgical system for simple prostatectomy, in which a surgeon removes part of an enlarged prostate.

The FDA also cleared the da Vinci SP surgical system for use in transvesical approaches to both simple and radical prostatectomies, the company said. In a radical prostatectomy, the surgeon removes the entire prostate gland, usually for patients who have been diagnosed with prostate cancer.

"There is a growing body of clinical evidence on the use of the SP system, and we look forward to continuing our efforts to safely advance minimally invasive surgery," Chief Medical Officer Myriam Curet said.

Intuitive Surgical's da Vinci SP system provides surgeons with robotic-assisted technology designed for deep and narrow access to tissue in the body.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

April 28, 2023 08:39 ET (12:39 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Intuitive Surgical (NASDAQ:ISRG)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Intuitive Surgical.
Intuitive Surgical (NASDAQ:ISRG)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Intuitive Surgical.